INTERLEUKIN-2 AND INTERFERON-ALPHA-2 COMBINATION - INEFFECTIVENESS OFA SINGLE 6-WEEK COURSE IN PATIENTS WITH METASTATIC RENAL-CANCER PRETREATED WITH INTERFERON ALONE
P. Pronzato et al., INTERLEUKIN-2 AND INTERFERON-ALPHA-2 COMBINATION - INEFFECTIVENESS OFA SINGLE 6-WEEK COURSE IN PATIENTS WITH METASTATIC RENAL-CANCER PRETREATED WITH INTERFERON ALONE, Oncology Reports, 3(6), 1996, pp. 1137-1139
We have studied activity and toxicity of subcutaneous recombinant inte
rleukin-2 and interferon alpha 2b in a series of 14 patients with adva
nced renal cell carcinoma. No objective response was observed, and the
median survival was 16 months (range 3-19); toxicity was acceptable.
All the patients had poor prognostic factors and were pretreated with
interferon.